81 related articles for article (PubMed ID: 24476133)
1. Inactivation of AKT induces cellular senescence in uterine leiomyoma.
Xu X; Lu Z; Qiang W; Vidimar V; Kong B; Kim JJ; Wei JJ
Endocrinology; 2014 Apr; 155(4):1510-9. PubMed ID: 24476133
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence in usual type uterine leiomyoma.
Laser J; Lee P; Wei JJ
Fertil Steril; 2010 Apr; 93(6):2020-6. PubMed ID: 19217096
[TBL] [Abstract][Full Text] [Related]
3. Clinical practice. Uterine fibroids.
Stewart EA
N Engl J Med; 2015 Apr; 372(17):1646-55. PubMed ID: 25901428
[TBL] [Abstract][Full Text] [Related]
4. Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.
Borahay MA; Al-Hendy A; Kilic GS; Boehning D
Mol Med; 2015 Apr; 21(1):242-56. PubMed ID: 25879625
[TBL] [Abstract][Full Text] [Related]
5. let-7 enhances osteogenesis and bone formation while repressing adipogenesis of human stromal/mesenchymal stem cells by regulating HMGA2.
Wei J; Li H; Wang S; Li T; Fan J; Liang X; Li J; Han Q; Zhu L; Fan L; Zhao RC
Stem Cells Dev; 2014 Jul; 23(13):1452-63. PubMed ID: 24617339
[TBL] [Abstract][Full Text] [Related]
6. Modulation of tumor plasticity by senescent cells: Deciphering basic mechanisms and survival pathways to unravel therapeutic options.
Silva AO; Bitencourt TC; Vargas JE; Fraga LR; Filippi-Chiela E
Genet Mol Biol; 2024; 47Suppl 1(Suppl 1):e20230311. PubMed ID: 38805699
[TBL] [Abstract][Full Text] [Related]
7. Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids.
Kuznetsova MV; Tonoyan NM; Trubnikova EV; Zelensky DV; Svirepova KA; Adamyan LV; Trofimov DY; Sukhikh GT
Diseases; 2023 Nov; 11(4):. PubMed ID: 37987267
[TBL] [Abstract][Full Text] [Related]
8. Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis.
Barnaś E; Skręt-Magierło JE; Paszek S; Kaznowska E; Potocka N; Skręt A; Sakowicz A; Zawlik I
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980984
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
Xiao D; Xie J; Wu S
Medicine (Baltimore); 2021 Jun; 100(22):e25830. PubMed ID: 34087825
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities.
El Sabeh M; Saha SK; Afrin S; Islam MS; Borahay MA
Mol Cell Biochem; 2021 Sep; 476(9):3513-3536. PubMed ID: 33999334
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to Osimertinib.
La Monica S; Fumarola C; Cretella D; Bonelli M; Minari R; Cavazzoni A; Digiacomo G; Galetti M; Volta F; Mancini M; Petronini PG; Tiseo M; Alfieri R
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374971
[TBL] [Abstract][Full Text] [Related]
12. Activation of protein kinase B by WNT4 as a regulator of uterine leiomyoma stem cell function.
Liu S; Yin P; Dotts AJ; Kujawa SA; Coon V JS; Wei JJ; Chakravarti D; Bulun SE
Fertil Steril; 2020 Dec; 114(6):1339-1349. PubMed ID: 32892998
[TBL] [Abstract][Full Text] [Related]
13. 4D Genome Rewiring during Oncogene-Induced and Replicative Senescence.
Sati S; Bonev B; Szabo Q; Jost D; Bensadoun P; Serra F; Loubiere V; Papadopoulos GL; Rivera-Mulia JC; Fritsch L; Bouret P; Castillo D; Gelpi JL; Orozco M; Vaillant C; Pellestor F; Bantignies F; Marti-Renom MA; Gilbert DM; Lemaitre JM; Cavalli G
Mol Cell; 2020 May; 78(3):522-538.e9. PubMed ID: 32220303
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas.
Shen Q; Zou S; Sheng B; Zhao M; Sun LZ; Zhu X
Drug Des Devel Ther; 2019; 13():3161-3170. PubMed ID: 31564832
[TBL] [Abstract][Full Text] [Related]
15. MiR-150-5p May Contribute to Pathogenesis of Human Leiomyoma via Regulation of the Akt/p27
Lee JH; Choi YS; Park JH; Kim H; Lee I; Won YB; Yun BH; Park JH; Seo SK; Lee BS; Cho S
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159158
[TBL] [Abstract][Full Text] [Related]
16. Application of ex-vivo spheroid model system for the analysis of senescence and senolytic phenotypes in uterine leiomyoma.
Xie J; Xu X; Yin P; Li Y; Guo H; Kujawa S; Chakravarti D; Bulun S; Kim JJ; Wei JJ
Lab Invest; 2018 Dec; 98(12):1575-1587. PubMed ID: 30206313
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress-induced miRNAs modulate AKT signaling and promote cellular senescence in uterine leiomyoma.
Xu X; Kim JJ; Li Y; Xie J; Shao C; Wei JJ
J Mol Med (Berl); 2018 Oct; 96(10):1095-1106. PubMed ID: 30097674
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.
Xie J; Ubango J; Ban Y; Chakravarti D; Kim JJ; Wei JJ
Genes Chromosomes Cancer; 2018 Oct; 57(10):485-494. PubMed ID: 29790226
[TBL] [Abstract][Full Text] [Related]
19. The AKT/BCL-2 Axis Mediates Survival of Uterine Leiomyoma in a Novel 3D Spheroid Model.
Vidimar V; Chakravarti D; Bulun SE; Yin P; Nowak R; Wei JJ; Kim JJ
Endocrinology; 2018 Mar; 159(3):1453-1462. PubMed ID: 29381777
[TBL] [Abstract][Full Text] [Related]
20. Asxl1 deficiency in embryonic fibroblasts leads to cellular senescence via impairment of the AKT-E2F pathway and Ezh2 inactivation.
Youn HS; Kim TY; Park UH; Moon ST; An SJ; Lee YK; Hwang JT; Kim EJ; Um SJ
Sci Rep; 2017 Jul; 7(1):5198. PubMed ID: 28701722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
